914 studies found for:    Open Studies | "Prostatic Diseases"
Show Display Options
Rank Status Study
21 Recruiting Evaluating the Impact of Prostate Only Versus Pelvic Radiation for N+ Prostate Cancer.
Condition: Prostate Cancer
Intervention: Radiation: radiotherapy
22 Recruiting Advanced Magnetic Resonance Imaging (MRI) in Men With Suspected Prostate Cancer
Condition: Prostate Cancer
Interventions: Procedure: TRUS Biopsy;   Procedure: TRUS/FUSION Biopsy
23 Recruiting Targeted Fusion Biopsy of the Prostate
Condition: Prostatic Neoplasms
Interventions: Drug: FACBC PET-CT Scan;   Procedure: Three-dimensional ultrasound-guided biopsy;   Procedure: Standard transrectal ultrasound (TRUS) guided biopsy
24 Recruiting Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)
Condition: Prostate Cancer
Interventions: Drug: Bicalutamide;   Drug: goserelin acetate;   Drug: flutamide;   Drug: leuprolide acetate;   Drug: triptorelin;   Procedure: Definitive Treatment
25 Not yet recruiting Validation of the Prostate Cancer Assay - Beta+Pivotal
Condition: Metastatic Prostate Cancer, CTC
Intervention: Device: Blood Draw
26 Recruiting Carbon Ion Radiotherapy for the Treatment of Localized Prostate Cancer
Condition: Prostate Carcinoma
Intervention: Device: carbon-ion radiotherapy
27 Recruiting Changes of Immunologic Function in Patients of Prostate Cancer Induced After Cryoablation.
Condition: Prostate Cancer
Intervention:
28 Recruiting A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Zytiga® (Abiraterone Acetate);   Drug: SoluMatrix™ (Abiraterone Acetate)
29 Recruiting HoLEP (50W) vs. HoLEP (100W) for Treatment of BPH
Condition: Prostatic Hyperplasia
Interventions: Procedure: Low power Holmium laser enucleation of the prostate;   Procedure: High power Holmium laser enucleation of the prostate
30 Not yet recruiting PROMOTE: Identifying Predictive Markers of Response for Prostate Cancer
Condition: Prostate Cancer
Intervention: Other: Systemic therapy
31 Recruiting Validation of Radioisotope Guided Lymphadenectomy for Loco-regional Staging in Patients With Intermediate or High-risk Prostate Cancer
Condition: Patient With Prostate Cancer
Interventions: Procedure: standard lymphadenectomy;   Procedure: lymphadenectomy radio-isotope method
32 Recruiting Pharmacokinetic Food-effect Study of Abiraterone Acetate (AA) in Castration Resistant Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: AA Reduced dose-normal diet (A);   Drug: AA reduced dose-fat diet (B);   Drug: AA normal dose-fasting conditions (C)
33 Recruiting INTense Exercise foR surVivAL Among Men With Metastatic Castrate-Resistant Prostate Cancer
Condition: Prostate Cancer Metastatic
Interventions: Behavioral: High intensity aerobic and resistance training;   Behavioral: Psychosocial support
34 Not yet recruiting Treatment Patterns in Metastatic Prostate Cancer
Condition: Prostatic Neoplasm
Intervention: Drug: Xofigo (Radium 223 dichloride,BAY88-8223)
35 Not yet recruiting A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Degarelix
36 Recruiting Nanocurcumin for Prostate Cancer Patients Undergoing Radiotherapy (RT)
Condition: Prostate Cancer
Interventions: Drug: Curcumin;   Radiation: RT;   Drug: Placebo
37 Not yet recruiting Validation of Decipher Test in African American Men With Prostate Cancer - VANDAAM
Condition: Prostate Cancer
Intervention: Other: Genomic Classifier (GC) Test
38 Recruiting Expression of Tumor Markers in Circulating Tumor Cells of Metastatic Hormone-sensitive Prostate Cancer
Condition: Prostate Cancer
Intervention: Other: Blood drawing
39 Recruiting Cardiac MRI in Measuring the Impact of Anti-androgen Treatment on Cardiac Function in Patients With Prostate Cancer
Conditions: Cardiovascular Injury;   Prostate Carcinoma
Interventions: Procedure: Magnetic Resonance Imaging;   Behavioral: Exercise Intervention;   Radiation: Gadopentetate Dimeglumine;   Procedure: Perfusion Magnetic Resonance Imaging;   Procedure: Spectroscopy;   Other: Laboratory Biomarker Analysis
40 Not yet recruiting ARN-509 in Treating Patients With Prostate Cancer Who Are in Active Surveillance
Condition: Stage II Prostate Adenocarcinoma
Interventions: Drug: Androgen Receptor Antagonist ARN-509;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years